Literature DB >> 18812573

High-throughput microsomal stability assay for screening new chemical entities in drug discovery.

Massimiliano Fonsi1, Maria V Orsale, Edith Monteagudo.   

Abstract

In this work, the authors present a novel, robotic, automated protocol for assessing a metabolic stability protocol assembled on a Hamilton platform and a new strategy for pooling samples (cassette analysis). To increase the high throughput of the liquid chromatography (LC) step, fast chromatography and automated liquid chromatography tandem mass spectrometry (LC/MS/MS) analytical methods were also developed, and a rapid data analysis system was generated that converts peak areas obtained by LC/MS/MS in intrinsic clearance values. All of the steps of the microsomal stability assay were carefully studied and optimized. Standard errors and confidence intervals of the measured clearances were also automatically generated in the process to allow an immediate evaluation of the significance of observed values. Methods based on pooling analysis of 2 and 4 different analytes were compared with a standard method without pooling. A simple statistical treatment was used to show their equivalence. The different protocols developed were analyzed in terms of the best compromise between accuracy and high-throughput capabilities.

Mesh:

Substances:

Year:  2008        PMID: 18812573     DOI: 10.1177/1087057108323911

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  4 in total

1.  Inhibitors of HIV-1 Nef-Mediated Activation of the Myeloid Src-Family Kinase Hck Block HIV-1 Replication in Macrophages and Disrupt MHC-I Downregulation.

Authors:  Lori A Emert-Sedlak; Omar Moukha-Chafiq; Haibin Shi; Shoucheng Du; John J Alvarado; Vibha Pathak; Samuel G Tanner; Robert N Hunter; Miranda Nebane; Li Chen; Tatiana V Ilina; Rieko Ishima; Sixue Zhang; Yury V Kuzmichev; Elizabeth R Wonderlich; Susan M Schader; Corinne E Augelli-Szafran; Roger G Ptak; Thomas E Smithgall
Journal:  ACS Infect Dis       Date:  2022-01-05       Impact factor: 5.578

2.  Development of a High-Throughput and Miniaturized Cytokinesis-Block Micronucleus Assay for Use as a Biological Dosimetry Population Triage Tool.

Authors:  Stanley W Lue; Mikhail Repin; Ryan Mahnke; David J Brenner
Journal:  Radiat Res       Date:  2015-07-31       Impact factor: 2.841

3.  Synthesis, inhibitory activity and oral dosing formulation of AV5124, the structural analogue of influenza virus endonuclease inhibitor baloxavir.

Authors:  Andrei A Ivashchenko; Oleg D Mitkin; Jeremy C Jones; Alexander V Nikitin; Angela G Koryakova; Ruben N Karapetian; Dmitry V Kravchenko; Stephan V Mochalov; Alexey A Ryakhovskiy; Vladimir Aladinskiy; Irina A Leneva; Irina N Falynskova; Ekaterina A Glubokova; Elena A Govorkova; Alexandre V Ivachtchenko
Journal:  J Antimicrob Chemother       Date:  2021-03-12       Impact factor: 5.790

4.  Development and validation of an HPLC-MS/MS method for the determination of arginine-vasopressin receptor blocker conivaptan in human plasma and rat liver microsomes: application to a metabolic stability study.

Authors:  Haitham Alrabiah; Adnan A Kadi; Mohamed W Attwa; Gamal A E Mostafa
Journal:  Chem Cent J       Date:  2018-05-02       Impact factor: 4.215

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.